More and more research and discovery projects aim to unlock the bright potential of mRNA for a new generation of medicines. To better understand this potential, three scientists share their insights from their rich experience working with mRNAs destined for clinical pipelines.

• Explore the challenges of mRNA, including usability, stability, and technological limits.
• Gain insights into developmental considerations for clinic-bound constructs.
• Discover the crucial role of characterizing and analyzing mRNA in the early stages of development.